Skip to content

DEBBIE-ASL Pilot

DEBBIE-ASL Pilot - DEBBIE-ASL Pilot

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51668
Enrollment
30
Registered
2023-01-13
Start date
2023-05-04
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor glioma

Interventions

None listed

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • age minimally 18 and legally able to give informed consent • both sexes allowed For patients: • patient of Amsterdam University Medical Centre, location VUmc, with high suspicion of de novo brain tumor or recurrent brain tumor patient receives clinically indicated MRI • no other concurrent brain pathology at the time of diagnosis For healthy volunteers: • no history of significant brain pathology

Exclusion criteria

Exclusion criteria: • Not fitting the inclusion criteria • Contraindication for MRI • Dependent relationship to PI (family, PhD student, etc.) Pregnant or breast-feeding

Design outcomes

Primary

MeasureTime frame
pilot study - absolute values of perfusion and permeability parameters with standard deviation - intraclass coefficient and Bland-Altman for repeatability

Secondary

MeasureTime frame
- classification possible according to tissue type (healthy, tumour, type of tumour)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)